BACKGROUND: Epstein-Barr virus (EBV) is closely associated with the development of a number of tumors. During latent infection, EBV continuously expresses a number of viral genes which are essential for cell transformation and maintenance of the malignant phenotype of EBV-related tumors. There has been no previous link between EBV and T-cell prolymphocytic leukemia (T-PLL), a distinctive form of leukemia derived from T-cells at an intermediate stage of differentiation between a cortical thymocyte and a mature peripheral blood T-cell. OBJECTIVE: To determine if EBV was present in the T-PLL cells collected. STUDY DESIGN: T-PLL cells were isolated from the peripheral blood of a patient diagnosed with T-PLL and continuously cultured for about 1 year. The existence of EBV in these cells was detected using multiple strategies including PCR, Western blotting, immunofluorescent assay and flow cytometry analysis. RESULTS: The EBV genome was present in these T-PLL cells by PCR analysis across multiple sites in the viral genome. In addition, these T-PLL cells expressed a number of EBV latent antigens. The EBV oncoproteins LMP1, EBNA1 and EBNA3C were expressed in the majority of the infected cells. CONCLUSION: This report suggests a potential link between EBV infection and T-PLL and provides new information about the potential contribution of EBV in the initiation or maintenance of T-PLL.
BACKGROUND:Epstein-Barr virus (EBV) is closely associated with the development of a number of tumors. During latent infection, EBV continuously expresses a number of viral genes which are essential for cell transformation and maintenance of the malignant phenotype of EBV-related tumors. There has been no previous link between EBV and T-cell prolymphocytic leukemia (T-PLL), a distinctive form of leukemia derived from T-cells at an intermediate stage of differentiation between a cortical thymocyte and a mature peripheral blood T-cell. OBJECTIVE: To determine if EBV was present in the T-PLL cells collected. STUDY DESIGN: T-PLL cells were isolated from the peripheral blood of a patient diagnosed with T-PLL and continuously cultured for about 1 year. The existence of EBV in these cells was detected using multiple strategies including PCR, Western blotting, immunofluorescent assay and flow cytometry analysis. RESULTS: The EBV genome was present in these T-PLL cells by PCR analysis across multiple sites in the viral genome. In addition, these T-PLL cells expressed a number of EBV latent antigens. The EBV oncoproteins LMP1, EBNA1 and EBNA3C were expressed in the majority of the infected cells. CONCLUSION: This report suggests a potential link between EBVinfection and T-PLL and provides new information about the potential contribution of EBV in the initiation or maintenance of T-PLL.
Authors: L Virgilio; M G Narducci; M Isobe; L G Billips; M D Cooper; C M Croce; G Russo Journal: Proc Natl Acad Sci U S A Date: 1994-12-20 Impact factor: 11.205
Authors: M G Narducci; L Virgilio; M Isobe; A Stoppacciaro; R Elli; M Fiorilli; M Carbonari; A Antonelli; L Chessa; C M Croce; G Russo Journal: Blood Date: 1995-09-15 Impact factor: 22.113
Authors: C M Croce; M Isobe; A Palumbo; J Puck; J Ming; D Tweardy; J Erikson; M Davis; G Rovera Journal: Science Date: 1985-03-01 Impact factor: 47.728